Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival PURPOSE: CD20 can be expressed in Hodgkin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback